ŞAKER, D. Et Al. 2024. Galantamine and wedelolactone combined treatment suppresses LPS-induced NLRP3 inflammasome activation in microglial cells. Immunopharmacology and Immunotoxicology .

ŞAKER, D., SENCAR, L., COŞKUN, G., Sapmaz Ercakalli, T., YILMAZ, D. M., & POLAT, S., (2024). Galantamine and wedelolactone combined treatment suppresses LPS-induced NLRP3 inflammasome activation in microglial cells. Immunopharmacology and Immunotoxicology .

ŞAKER, DİLEK Et Al. "Galantamine and wedelolactone combined treatment suppresses LPS-induced NLRP3 inflammasome activation in microglial cells," Immunopharmacology and Immunotoxicology , 2024

ŞAKER, DİLEK Et Al. "Galantamine and wedelolactone combined treatment suppresses LPS-induced NLRP3 inflammasome activation in microglial cells." Immunopharmacology and Immunotoxicology , 2024

ŞAKER, D. Et Al. (2024) . "Galantamine and wedelolactone combined treatment suppresses LPS-induced NLRP3 inflammasome activation in microglial cells." Immunopharmacology and Immunotoxicology .

@article{article, author={DİLEK ŞAKER Et Al. }, title={Galantamine and wedelolactone combined treatment suppresses LPS-induced NLRP3 inflammasome activation in microglial cells}, journal={Immunopharmacology and Immunotoxicology}, year=2024}